Plasma with antibodies from already cured patients

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $691,501.32
  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Principle Investigator

    Pending
  • Research Location

    Spain, Europe
  • Lead Research Institution

    Instituto de Investigación Sanitaria Puerta de Hierro de Majadahonda
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Plasma with antibodies from already cured patients TT: plasma con anticuerpos de pacientes ya curados